Baker & Eastlack Ventures
VC Fund
San Diego, United States
Baker & Eastlack Ventures is a VC fund in San Diego focused on Medical and Health Care. Baker & Eastlack Ventures invests in early stage medical devices and diagnostics.They have deep experience in patient care, healthcare, investing, and corporate operations.
- Total investments:
- 7
- Last investment:
- Lead investor:
- 14%
Last updated:
For AI agents: llms.txt
Industries Baker & Eastlack Ventures invests in
Stages Baker & Eastlack Ventures invests in
Countries Baker & Eastlack Ventures invests in
Contacts
| Name | Phone | Socials | |
|---|---|---|---|
|
Kenneth Baker
|
|||
|
Robert Eastlack
|
|||
Investment Focus
Industry
- Medical 4 (57%)
- Health Care 4 (57%)
- Medical Device 4 (57%)
- Biotechnology 3 (43%)
- Biopharma 2 (29%)
Stage
- Venture - Series Unknown 4 (57%)
- Seed 3 (43%)
Team
| Name | Title | Investments | Links | |
|---|---|---|---|---|
|
Kenneth Baker
Partner & Co-Founder
|
Partner & Co-Founder | Total investments: 0 | Find email | |
|
Robert Eastlack
Partner & Co-Founder
|
Partner & Co-Founder | Total investments: 0 | Find email |
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| OcuDoc Mobile is a product of OcuDoc, Inc, a Columbus, Ohio-based MedTech startup that develops and markets innovations in eyecare technologies. OcuDoc Mobile is the first and only standalone smartphone app that can provide accurate, fast, objective autorefraction and Telerefraction, all without the need for additional equipment. | $2.5M / Venture - Series Unknown / Feb 15, 2023 | ||
| MatriSys sees commercialization paths for its intellectual property in topical dermatology therapeutics, cosmetics, and skin care. The company’s lead live biologic therapeutic is currently in Phase I/II clinical trials targeting atopic dermatitis (commonly referred to as AD or eczema) patients. | Seed / Oct 08, 2018 | ||
| Clarify Medical is innovating a well-established treatment, UVB therapy, to become easier, more convenient, more empowering, and more connected for psoriasis, eczema and vitiligo patients. The company also focused on developing innovative technology, products, and services that improve care for people with chronic skin conditions.Clarify Medicalindicated for the localized phototherapeutic treatment of dermatologic conditions such as psoriasis, vitiligo, atopic dermatitis (eczema), seborrheic dermatitis, and leukoderma on all skin types (I-VI). It is the first and only connected phototherapy system that uses an app on the patient’s own smartphone (iOS or Android) to manage the dose, frequency, and duration of UVB light therapy, helping to ensure that patients receive the proper doses recommended by the American Academy of Dermatology and Vitiligo Working Group. The treatment regimen is prescribed by the patient’s physician but monitored and controlled by the Clarify System, enabling patients to administer treatment with clinical precision in the convenience of their homes. The connected system monitors dosing, adherence, compliance, patient progress, and satisfaction. | $1M / Venture - Series Unknown / Jul 03, 2018 | ||
| Lentechs is a medical device company that develops a novel soft bifocal contact lens. The company is headquartered in Columbus, Ohio. | Seed / Mar 22, 2018 | ||
| Neurvana Medical is dedicated to the development of neurovascular therapeutic devices. | $3.2M / Venture - Series Unknown / Oct 23, 2017 | ||
| UroDev Medical designs devices to improve the quality of life for people with Spinal Cord Injury and Disease. Their first product, The Connected Catheter, will revolutionize the way millions of people deal manage their bladders. | $3.2M / Seed / Sep 27, 2017 | ||
| Kurin® is a privately held, certified minority owned business dedicated to engineering better healthcare through innovative, cost-effective, clinician-approved technologies.Building on the successful invention, clinical adoption and corporate acquisition of Curos™ disinfecting port protectors, Kurin is focusing its depth of experience inmedical device engineering, marketing, sales and service, to tackle the persistent and costly fallout of false positive blood cultures. With agile development capabilities and intense customer focus, we expect the Kurin Lock technology to quickly gain caregiver acceptance, reduce blood culture contamination and become the standard of care in hospitals. | $2.3M / Venture - Series Unknown / Oct 06, 2016 |
Co-Investors
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does Baker & Eastlack Ventures invest in?
Baker & Eastlack Ventures invests primarily in Medical, Health Care and Medical Device startups, most often at Venture - Series Unknown and Seed stage. Most of the 7 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact Baker & Eastlack Ventures?
Public channels for Baker & Eastlack Ventures include the website linked on this profile. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
Who are the partners at Baker & Eastlack Ventures?
The team at Baker & Eastlack Ventures includes Kenneth Baker (Partner & Co-Founder) and Robert Eastlack (Partner & Co-Founder). The Team section lists each member with their title, investment count and links.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!